Over the 90-day window ending February 07, 2026, Madrigal Pharmaceuticals's three dominant insider ownership positions are held by Director Bros. Advisors Lp Baker (1.86Mn shares), Director Rebecca Taub (452.70K shares), Director Fred B Craves (361.08K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Bros. Advisors Lp Baker | 1,859,091 | 20 Aug, 2025 | |
| Rebecca Taub | 452,704 | 26 Jan, 2026 | |
| Fred B Craves | 361,076 | 14 Mar, 2025 | |
| Paul A Friedman | 187,164 | 13 Jan, 2026 | |
| William John Sibold | President And Ceo | 148,497 | 26 Jan, 2026 |
| Richard S Levy | 25,197 | 26 Jan, 2026 | |
| Alex G. Howarth | Chief Financial Officer | 18,737 | 25 Jan, 2024 |
| Brian Joseph Lynch | Svp And General Counsel | 17,691 | 25 Jan, 2024 |
| Remy Sukhija | Chief Commercial Officer | 15,001 | 18 Jan, 2023 |
| Mardi Dier | Evp And Cfo | 10,440 | 03 Dec, 2025 |
| Carole Huntsman | Chief Commercial Officer | 9,122 | 26 Jan, 2026 |
| Shannon T Kelley | General Counsel | 8,481 | 20 Jan, 2026 |
| David Soergel | Chief Medical Officer | 7,545 | 16 May, 2025 |
| Robert E. Waltermire | Senior Vp And Chief Pharma Dev. | 5,789 | 07 Mar, 2025 |
| James M Daly | 2,627 | 24 Jun, 2025 | |
| Kenneth Bate | 2,627 | 07 Nov, 2025 | |
| Rita Thakkar | Chief Accounting Officer | 2,398 | 20 Jan, 2026 |
| City Capital Llc Bay | 1,261 | 07 Dec, 2021 | |
| Jacqualyn A Fouse | 1,097 | 24 Jun, 2025 | |
| Daniel J. Brennan | 967 | 05 Aug, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 26 Jan, 2026 | Rebecca Taub | Common Stock | D | 647 | $492.42 | 452,704 | D | S |
| 26 Jan, 2026 | Richard S Levy | Common Stock | A | 4,000 | $16.46 | 25,197 | D | M |
| 26 Jan, 2026 | William John Sibold | Common Stock | D | 1,577 | $492.42 | 148,497 | D | S |
| 26 Jan, 2026 | Carole Huntsman | Common Stock | D | 340 | $492.42 | 9,692 | D | S |
| 26 Jan, 2026 | Carole Huntsman | Common Stock | D | 570 | $494.59 | 9,122 | D | S |
| 20 Jan, 2026 | Rebecca Taub | Common Stock | D | 2,238 | $490.77 | 453,351 | D | S |
| 20 Jan, 2026 | Shannon T Kelley | Common Stock | D | 263 | $490.77 | 8,910 | D | S |
| 20 Jan, 2026 | Shannon T Kelley | Common Stock | D | 429 | $501.40 | 8,481 | D | S |
| 15 Jan, 2026 | Rita Thakkar | Common Stock | A | 2,398 | $0.00 | 2,398 | D | A |
| 09 Jan, 2026 | Paul A Friedman | Common Stock | D | 575 | $528.18 | 191,021 | D | S |
| 09 Jan, 2026 | Paul A Friedman | Common Stock | D | 970 | $523.00 | 197,853 | D | S |
| 09 Jan, 2026 | Paul A Friedman | Common Stock | D | 1,094 | $513.11 | 209,110 | D | S |
| 09 Jan, 2026 | Paul A Friedman | Common Stock | D | 1,066 | $526.00 | 193,156 | D | S |
| 09 Jan, 2026 | Paul A Friedman | Common Stock | D | 280 | $551.24 | 187,164 | D | S |
| 09 Jan, 2026 | Paul A Friedman | Common Stock | D | 148 | $535.29 | 189,324 | D | S |
| 09 Jan, 2026 | Paul A Friedman | Common Stock | D | 332 | $534.16 | 189,472 | D | S |
| 09 Jan, 2026 | Paul A Friedman | Common Stock | D | 1,363 | $518.68 | 201,190 | D | S |
| 09 Jan, 2026 | Paul A Friedman | Common Stock | D | 846 | $519.88 | 200,344 | D | S |
| 09 Jan, 2026 | Paul A Friedman | Common Stock | D | 1,560 | $526.97 | 191,596 | D | S |
| 09 Jan, 2026 | Paul A Friedman | Common Stock | D | 840 | $521.98 | 198,823 | D | S |